TREAT PTSD VA Act
Summary
The TREAT PTSD VA Act (HR8763) is an early-stage bill that would require the VA to offer stellate ganglion block (SGB) to veterans with PTSD. The bill authorizes no funding and is in committee. No near-term market impact is expected.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Bill is early-stage with no funding authorization
- 2.No material impact on any publicly traded company
- 3.SGB is a procedure using generic drugs, not a patented product
Market Implications
No market implications. The bill does not allocate funds, create a procurement program, or affect any publicly traded company's revenue. Investors should ignore this bill until it advances to appropriations stage.
Full Analysis
- On May 12, 2026, Rep. Scott Perry (R-PA) introduced HR8763, the TREAT PTSD VA Act, which was referred to the House Committee on Veterans' Affairs. The bill is in early stage with no further action. 2) The bill mandates the VA to update its PTSD clinical practice guideline and offer SGB as a therapy option, but does not appropriate any funds. SGB is a procedure using generic local anesthetics (lidocaine/bupivacaine), not a patented drug or device. 3) No public companies are directly or materially affected. The bill does not create a procurement program, reimbursement code, or funding stream. Generic drug manufacturers (Pfizer, Fresenius, Baxter) supply lidocaine but volumes are negligible. 4) No real market data is provided. The competitive landscape for SGB is dominated by hospital systems and pain clinics, not publicly traded pure-plays. 5) The bill must pass committee, then the House, then the Senate, then be signed into law. Even if enacted, the effective date is 180 days later. No timeline for committee markup.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
The bill mandates the VA to furnish stellate ganglion block (SGB) to veterans with PTSD, but does not specify any funding or procurement for SGB. SGB is a medical procedure, not a drug or vaccine. No direct impact on mRNA-based therapeutics or vaccines.
Who must act
Department of Veterans Affairs (VA) medical facilities and contracted healthcare providers
What happens
VA must update clinical guidelines and offer SGB as a therapy option, but no new procurement or reimbursement mechanism is established. The bill does not allocate funds for SGB training, equipment, or administration.
Stock impact
MRNA has no approved SGB product or pipeline. SGB is a local anesthetic injection (typically lidocaine or bupivacaine) performed by anesthesiologists or pain specialists. No revenue impact from this bill.
What the bill does
Same as above. SGB is a procedure using generic local anesthetics. Pfizer manufactures lidocaine and bupivacaine, but these are low-cost generics with minimal revenue contribution. No new procurement mandate or funding.
Who must act
VA medical facilities and contracted providers
What happens
Potential slight increase in demand for generic local anesthetics, but volume is negligible relative to Pfizer's total revenue (~$50B annually).
Stock impact
Pfizer's hospital injectables segment includes lidocaine, but SGB volumes for ~1 million veterans with PTSD would represent <0.01% of Pfizer's revenue.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
MILLBROOK SUPPORT SERVICES INC: $12.8M Department of Veterans Affairs Contract
HELP Copays Act
Wildlife Health Coordination and Zoonotic Disease Prevention Act of 2026
A bill to require continued participation by the United States in the World Health Organization, and for other purposes.
SAFE Drugs Act of 2026
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $773M Department of Veterans Affairs Contract
TRIWEST HEALTHCARE ALLIANCE CORP: $874M Department of Veterans Affairs Contract
TRIWEST HEALTHCARE ALLIANCE CORP: $903M Department of Veterans Affairs Contract
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →